UCB PHARMA LIMITED
Get an alert when UCB PHARMA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-22 (this month)
Last made up 2025-05-08
Watchouts
None on the register
Cash
£571K
+18,933.3% vs 2023
Net assets
£84M
-38% vs 2023
Employees
221
+3.8% vs 2023
Profit before tax
£12M
-85.7% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £119,311,000 | £132,647,000 | |
| Operating profit | £76,955,000 | £5,789,000 | |
| Profit before tax | £84,007,000 | £12,028,000 | |
| Net profit | £65,004,000 | £8,340,000 | |
| Cash | £3,000 | £571,000 | |
| Total assets less current liabilities | £134,824,000 | £83,547,000 | |
| Net assets | £134,814,000 | £83,546,000 | |
| Equity | £134,814,000 | £83,546,000 | |
| Average employees | 213 | 221 | |
| Wages | £22,430,000 | £27,281,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 64.5% | 4.4% | |
| Net margin | 54.5% | 6.3% | |
| Return on capital employed | 57.1% | 6.9% | |
| Current ratio | 3.04x | 2.12x | |
| Interest cover | 950.06x | 42.88x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis, which assumes that the Company will continue trading for a period of at least 12 months from the date of these financial statements. Directors reviewed sales forecasts, cash flow projections, and growth drivers and concluded sufficient liquidity to pay creditors.”
Significant events
- “Subsequent to the balance sheet date, the company submitted a claim to HMRC for the recovery of VAT previously paid in respect of rebates under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) and Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 62 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KHATRI, Yogesh | Director | 2013-06-24 | Oct 1965 | British |
| PRICE, Steven Craig | Director | 2010-04-19 | Nov 1969 | British |
| REYNDERS, Nico Victor | Director | 2024-12-01 | Aug 1972 | Belgian |
Show 62 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HARDY, Mark Glyn | Secretary | 2004-10-29 | 2023-10-01 |
| HARDY, Mark Glyn | Secretary | — | 1996-07-25 |
| MURPHY, John | Secretary | 1996-07-25 | 2001-01-31 |
| SLATER, John Andrew Duncan | Secretary | 2001-01-31 | 2004-10-29 |
| ALLEN, Peter Vance | Director | 2000-10-31 | 2004-12-17 |
| ANDO, Goran Albert Torstensson, Doctor | Director | 2003-04-16 | 2004-10-29 |
| ARNOLD, Stephen | Director | 2013-04-08 | 2015-04-06 |
| BAINS, Harbinder Singh | Director | 2005-01-13 | 2006-02-01 |
| BATES, Malcolm Edwin | Director | — | 2000-05-31 |
| BLANCO, Hannah Victoria | Director | 2014-09-16 | 2015-09-25 |
| BOGIE, William, Dr | Director | 1993-04-01 | 2000-03-16 |
| BRADING, Claire | Director | 2021-01-01 | 2024-12-01 |
| BUFTON, Roland John Lewis | Director | — | 1998-07-06 |
| CARTMELL, Simon Christopher | Director | 2000-10-31 | 2002-06-28 |
| CNOPS, Willy Constant | Director | 2016-01-12 | 2019-12-01 |
| COOMBES, Dan | Director | 2018-10-08 | 2021-01-01 |
| COZENS, Peter John, Doctor | Director | 1994-09-28 | 2000-07-31 |
| D' HAMALE, Michele De Cannart | Director | 2008-01-01 | 2011-07-01 |
| DAMIEN, Vincent | Director | 2006-01-01 | 2009-12-31 |
| DOLIVEUX, Frederic Roch | Director | 2005-01-13 | 2005-05-12 |
| DUNCAN, Greg | Director | 2007-11-30 | 2009-04-30 |
| FARGHER, Adina-Lee Rudston | Director | 2013-05-21 | 2017-02-10 |
| FELLNER, Peter John, Dr | Director | 2000-10-31 | 2003-04-16 |
| FERGUSON, John | Director | — | 2001-04-06 |
| GERARD, William Wilson | Director | — | 1993-12-10 |
| HARDY, Mark Glyn | Director | 1996-07-25 | 2023-10-01 |
| HARRIS, Ralph Stephen | Director | 1994-09-28 | 1995-04-27 |
| HARRIS, Ralph Stephen | Director | — | 1993-12-10 |
| HARVEY, Michael John | Director | — | 2000-01-31 |
| INFANTE GONZALEZ DE LA ALEJA, Ana Isabel | Director | 2022-05-25 | 2024-12-01 |
| IVERSEN, Bo Kjelgaard | Director | 2010-11-01 | 2016-03-17 |
| JONES, Stephen Charles | Director | 2006-02-01 | 2013-06-30 |
| KHOSO BALUCH, Mohammed Nazir | Director | 2010-04-19 | 2016-01-12 |
| LEES, David John | Director | — | 1993-12-10 |
| LEWIS, Pamela Mary, Dr | Director | 1992-05-09 | 1993-12-10 |
| LOOMAN, Simon | Director | 2005-01-13 | 2008-12-31 |
| LURQUIN, Michel | Director | 2005-10-01 | 2008-12-31 |
| MABON, George David | Director | 1992-11-01 | 1994-03-31 |
| MCDADE, Mark Daniel | Director | 2009-04-30 | 2012-04-02 |
| MCHALE, Richard Michael | Director | 2008-05-19 | 2009-04-30 |
| MCHALE, Richard Michael | Director | 2003-12-04 | 2008-03-01 |
| MILLARD, Dennis Henry | Director | 1994-03-30 | 1996-02-29 |
| MOREAU, Jean-Luc | Director | 2014-11-03 | 2015-04-30 |
| NICHOLLS, Peter Geoffrey | Director | 2005-01-31 | 2009-10-02 |
| OLUWA, Olufunlayo Modupe | Director | 2024-01-01 | 2024-12-01 |
| REDRUP, Stephen John | Director | 1994-07-04 | 2000-02-29 |
| ROBINSON, William | Director | 2005-05-12 | 2007-12-12 |
| ROEDER, Stephan | Director | 2007-11-30 | 2008-09-01 |
| ROELANDT, Erik | Director | 2007-11-01 | 2010-07-24 |
| SAUNDERS, Ingelise | Director | 2002-07-23 | 2004-09-14 |
| SHEPPARD, Alan | Director | 1995-09-01 | 1999-08-27 |
| SPEERS, Matthew John Norton | Director | 2008-03-01 | 2012-12-31 |
| STRIGINI, Bruno | Director | 2005-01-13 | 2006-02-01 |
| TAYLOR, Bernard David | Director | — | 1993-12-10 |
| TELLIER, Jean-Christophe Pierre | Director | 2012-04-02 | 2014-11-03 |
| TURLEY, Stephen | Director | 2015-11-02 | 2018-10-08 |
| TURNER, Roger John Langdon | Director | — | 1992-11-30 |
| UPCHURCH, Francis Charles, Dr | Director | 1997-09-01 | 2001-02-05 |
| VILLA, Ilaria | Director | 2019-12-01 | 2022-05-20 |
| WATTS, Garry | Director | 1996-02-29 | 2000-09-30 |
| WATY, Philippe | Director | 2008-01-01 | 2011-04-30 |
| YOUNG, Michael, Dr | Director | 1995-06-27 | 2000-09-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Celltech Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 289 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-08-13 | AA | accounts | Accounts with accounts type full | |
| 2025-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-12-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-22 | AA | accounts | Accounts with accounts type full | |
| 2024-05-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-04 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-06 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-10-06 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-09 | AA | accounts | Accounts with accounts type full | |
| 2023-05-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-24 | AA | accounts | Accounts with accounts type full | |
| 2022-06-02 | TM01 | officers | Termination director company with name termination date | |
| 2022-06-02 | AP01 | officers | Appoint person director company with name date | |
| 2022-05-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-01-21 | AUD | auditors | Auditors resignation company | |
| 2021-05-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-05-17 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+11.2%
£119,311,000 £132,647,000
-
Cash
+18,933.3%
£3,000 £571,000
-
Net assets
-38%
£134,814,000 £83,546,000
-
Employees
+3.8%
213 221
-
Operating profit
-92.5%
£76,955,000 £5,789,000
-
Profit before tax
-85.7%
£84,007,000 £12,028,000
-
Wages
+21.6%
£22,430,000 £27,281,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers